The Education Department is among several agencies cutting funds to the school for allegedly failing to protect Jewish students from antisemitism on campus. The president says some nonprofit ...

ED is most often treated with lifestyle changes and medications. In 1998, the Food and Drug Administration (FDA) approved Viagra, the first medication to treat ED. Viagra works by helping the ...

Neurocrine (NBIX) Biosciences announced top-line data from a Phase 4 study, KINECT-PRO, demonstrating clinically meaningful and sustained effects of INGREZZA capsules on the physical, social and ...

SAN DIEGO, Feb. 25, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in March. (PRNewsfoto ...

Gary Lawson and I argue in a new book, The Meese Revolution: The Making of a Constitutional Moment, that Ed Meese was the most influential attorney general in American history. It is impossible to ...

The science journalist and author Ed Yong likes to joke that during the first wave of Covid-19 in 2020, the impact and reach of his reporting for The Atlantic turned him into “a character in the ...

For the year to December 2024, Neurocrine Biosciences had an accrual ratio of -0.15. Therefore, its statutory earnings were very significantly less than its free cashflow. To wit, it produced free ...

For the year to December 2024, Neurocrine Biosciences had an accrual ratio of -0.15. Therefore, its statutory earnings were very significantly less than its free cashflow. To wit, it produced free ...

(RTTNews) - Neurocrine Biosciences, Inc. (NBIX) said its Board has authorized a new share repurchase program under which Neurocrine may repurchase up to $500 million of its shares. The new share ...

SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Board of Directors has authorized a new share repurchase program under which ...

Analysts' ratings for Neurocrine Biosciences NBIX over the last quarter vary from bullish to bearish, as provided by 15 analysts. The table below offers a condensed view of their recent ratings ...